Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System

Introduction. A new homogeneous immunoassay for detection of primary infection of Treponema Pallidum (TP) on Vitros® 5600 Integrated System was evaluated.The scope of the study was to verify analytical performances and diagnostic accuracy in comparison to commercial methods (Immunoblotting test, ELI...

Full description

Bibliographic Details
Main Authors: Giusy Longo, Cosimo Bitella, Margherita La Motta, Ruggero Lucini, Fabio Rota, Antonio Godani Serra, Emanuele Vigo
Format: Article
Language:English
Published: PAGEPress Publications 2010-12-01
Series:Microbiologia Medica
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/mm/article/view/2395
id doaj-4fb68031f8844cb68fc1442fb83353f3
record_format Article
spelling doaj-4fb68031f8844cb68fc1442fb83353f32020-11-25T03:39:33ZengPAGEPress PublicationsMicrobiologia Medica 2280-64232010-12-0125410.4081/mm.2010.23951650Evaluation of a new Syphilis assay on Vitros® 5600 Integrated SystemGiusy LongoCosimo BitellaMargherita La MottaRuggero LuciniFabio RotaAntonio Godani SerraEmanuele VigoIntroduction. A new homogeneous immunoassay for detection of primary infection of Treponema Pallidum (TP) on Vitros® 5600 Integrated System was evaluated.The scope of the study was to verify analytical performances and diagnostic accuracy in comparison to commercial methods (Immunoblotting test, ELISA test, Immunoturbidimetric test). Methods. The new Syphilis assay from SENTINEL CH. SpA, is an immunoturbidimetric assay, using microparticles coated with TP fixed on the surface of polystyrene latex particles which agglutinate by an antigen-antibody reaction when anti-TP antigen is present in the specimen. The assay was implemented on Vitros® 5600 Integrated System. Modified CLSI protocols were adopted. Acceptance criteria for total imprecision were 5% for negative samples (or SD 0.5 U/mL) and 4% for positive samples. In comparison to commercial methods, sensitivity must be 99.5% and specificity 99.5%. Results. Total imprecision (22 days) gave SD at 6 U/mL lower than 0.5 U/mL, and CV% at 10 U/mL and 45 U/mL lower than 4%. Low quantitation limit is 5 U/mL. No prozone up to 13000 U/mL was found. In the on-board calibration stability study no drift was found up to 4 weeks. 153 samples were tested vs immunoblotting method and specificity was 100%, sensitivity was 100%. 495 samples were tested vs ELISA method and test specificity and sensitivity were 99.6% and 100% respectively. 521 samples were tested vs immunoturbidimetric method and specificity was 99.8%, sensitivity was 100%. Interference from Bilirubin (20 mg/dL), Hemoglobin (500 mg/dL) and Triglycerides (1000 mg/dL) was not detected.All the sample collection tubes tested (K2EDTA, SST, LH PST II, LH, NH) did not interfere with the assay. Conclusion. Performances of the new SENTINEL Syphilis assay on Vitros® 5600 Integrated System meet the requirements for its use as screening tool in blood bank, thus allowing consolidation with general chemistry on a single high volume chemistry analyzer, which is highly valuable for optimizing workflow and efficiency in today’s laboratories.http://www.pagepressjournals.org/index.php/mm/article/view/2395Syphilis, Immunoturbidimetric assay, Integrated system
collection DOAJ
language English
format Article
sources DOAJ
author Giusy Longo
Cosimo Bitella
Margherita La Motta
Ruggero Lucini
Fabio Rota
Antonio Godani Serra
Emanuele Vigo
spellingShingle Giusy Longo
Cosimo Bitella
Margherita La Motta
Ruggero Lucini
Fabio Rota
Antonio Godani Serra
Emanuele Vigo
Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System
Microbiologia Medica
Syphilis, Immunoturbidimetric assay, Integrated system
author_facet Giusy Longo
Cosimo Bitella
Margherita La Motta
Ruggero Lucini
Fabio Rota
Antonio Godani Serra
Emanuele Vigo
author_sort Giusy Longo
title Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System
title_short Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System
title_full Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System
title_fullStr Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System
title_full_unstemmed Evaluation of a new Syphilis assay on Vitros® 5600 Integrated System
title_sort evaluation of a new syphilis assay on vitros® 5600 integrated system
publisher PAGEPress Publications
series Microbiologia Medica
issn 2280-6423
publishDate 2010-12-01
description Introduction. A new homogeneous immunoassay for detection of primary infection of Treponema Pallidum (TP) on Vitros® 5600 Integrated System was evaluated.The scope of the study was to verify analytical performances and diagnostic accuracy in comparison to commercial methods (Immunoblotting test, ELISA test, Immunoturbidimetric test). Methods. The new Syphilis assay from SENTINEL CH. SpA, is an immunoturbidimetric assay, using microparticles coated with TP fixed on the surface of polystyrene latex particles which agglutinate by an antigen-antibody reaction when anti-TP antigen is present in the specimen. The assay was implemented on Vitros® 5600 Integrated System. Modified CLSI protocols were adopted. Acceptance criteria for total imprecision were 5% for negative samples (or SD 0.5 U/mL) and 4% for positive samples. In comparison to commercial methods, sensitivity must be 99.5% and specificity 99.5%. Results. Total imprecision (22 days) gave SD at 6 U/mL lower than 0.5 U/mL, and CV% at 10 U/mL and 45 U/mL lower than 4%. Low quantitation limit is 5 U/mL. No prozone up to 13000 U/mL was found. In the on-board calibration stability study no drift was found up to 4 weeks. 153 samples were tested vs immunoblotting method and specificity was 100%, sensitivity was 100%. 495 samples were tested vs ELISA method and test specificity and sensitivity were 99.6% and 100% respectively. 521 samples were tested vs immunoturbidimetric method and specificity was 99.8%, sensitivity was 100%. Interference from Bilirubin (20 mg/dL), Hemoglobin (500 mg/dL) and Triglycerides (1000 mg/dL) was not detected.All the sample collection tubes tested (K2EDTA, SST, LH PST II, LH, NH) did not interfere with the assay. Conclusion. Performances of the new SENTINEL Syphilis assay on Vitros® 5600 Integrated System meet the requirements for its use as screening tool in blood bank, thus allowing consolidation with general chemistry on a single high volume chemistry analyzer, which is highly valuable for optimizing workflow and efficiency in today’s laboratories.
topic Syphilis, Immunoturbidimetric assay, Integrated system
url http://www.pagepressjournals.org/index.php/mm/article/view/2395
work_keys_str_mv AT giusylongo evaluationofanewsyphilisassayonvitros5600integratedsystem
AT cosimobitella evaluationofanewsyphilisassayonvitros5600integratedsystem
AT margheritalamotta evaluationofanewsyphilisassayonvitros5600integratedsystem
AT ruggerolucini evaluationofanewsyphilisassayonvitros5600integratedsystem
AT fabiorota evaluationofanewsyphilisassayonvitros5600integratedsystem
AT antoniogodaniserra evaluationofanewsyphilisassayonvitros5600integratedsystem
AT emanuelevigo evaluationofanewsyphilisassayonvitros5600integratedsystem
_version_ 1724538037251080192